Found: 4 articles
Article | Edition |
---|---|
M.M. Kostik, M.F. Dubko, E.A. Isupova, I.A. Chikova, E.A. Gaydar, V. V. Masalova, L.S. Snegireva, O.V. Kalashnikova, V.G. Chasnyk
FACTORS CONTRIBUTING TO THE ACHIEVEMENT OF REMISSION AND DEVELOPMENT OF EXACERBATIONS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS WITH NO SYSTEMIC MANIFESTATIONS, RECEIVING THERAPY WITH ADALIMUMAB
|
№7 / 2016 |
V.V. Ryazhenov (1, 2), S.G. Gorokhov (2, 3), E.R. Volkova (2)
PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF MONOTHERAPY WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS
|
№7 / 2015 |
I.Yu. Zinchuk
PHARMACOECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICAL PRODUCTS USED IN THE TREATMENT OF PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
|
№7 / 2014 |
S.S. Vakhlyarskaya, I.V. Kondratenko, A.A. Bologov
Efficacy And Safety Of Adalimumab In The Treatment Of Juvenile Rheumatoid Arthritis
|
№6 / 2012 |